Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

U.S. stocks decline amid fiscal jitters; Dow Jones down 0.46%

Published 01/07/2013, 09:47 AM

Investing.com - U.S. stocks opened lower on Monday, as concerns over a potential slowdown of the U.S. job market coupled with worries over upcoming U.S. debt ceiling discussions weighed on investor confidence.

During early U.S. trade, the Dow Jones Industrial Average dropped 0.46%, the S&P 500 index declined 0.44%, while the Nasdaq Composite index retreated 0.40%.

On Friday, the U.S. Department of Labor said the economy added 155,000 jobs in December, slightly higher than forecasts for an increase of 150,000, but easing from an upwardly revised increase of 161,000 in November, suggesting that the recovery in the labor market may be slowing.

The data came one day after the minutes of the Federal Reserves’ December policy meeting showed that some policymakers considered an earlier-than-expected end to the bank’s quantitative easing program.

Investors also remained cautious over the longer term outlook in the U.S., with negotiations on raising the debt ceiling still to come in February.

Financial stocks were broadly lower, as shares in Bank of America slipped 0.25% and JP Morgan dropped 0.46%, while Goldman Sachs and Citigroup declined 0.64% and 0.66% respectively.

Citigroup's Michael Corbat was said to have been meeting bank regulators in his first months as CEO, with hopes of bolstering relationships and finalize the bank's plan to return capital to shareholders.

Separately, the Basel Committee for Banking Supervision, a group of the world's top regulators and central bankers, on Sunday agreed to give banks four more years to build up cash reserves.

Meanwhile, Bank of America reached a USD10 billion settlement with Fannie Mae over mortgage repurchases.

In the Internet sector, Yahoo plummeted 1.46% after the company's shares were downgraded to market perform from outperform at Bernstein.

Elsewhere, Illumina dove 8.52% after Swiss group Roche said that its takeover bid is "off the table".

In addition, Illumina agreed to buy Verinata Health Inc. for USD350 million plus up to USD100 million in milestone payments through 2015.

Across the Atlantic, European stock markets were lower. The EURO STOXX 50 dropped 0.47%, France’s CAC 40 retreated 0.66%, Germany's DAX declined 0.55%, while Britain's FTSE 100 slipped 0.33%.

During the Asian trading session, Hong Kong's Hang Seng Index inched 0.01% lower, while Japan’s Nikkei 225 Index dropped 0.83%.


3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.